Skip to main content

Healthy Ideas, Healthy Returns

Together we support the entrepreneurs who build our healthy future

The invitation only Benelux platform for tomorrow’s academic Health ventures.

Connect with our Human Health community of knowledge institutes, spin-off initiatives, investors and industry partners.

HIHR offers valuable networking opportunities, allowing spin-offs to build up contacts for investments in follow-up programs, as well as a good feedback to sharpen their propositions.

Our practitioner driven network that brings together around hundred investors, spin-offs and TTO-professionals within the Benelux is growing fast.

Spin-off initiatives

Connect with investors and industry partners.

During the preparations and sessions itself you will get highly valued feedback, preparing you to connect with leading companies and investors in the medical innovation field.

Public Research Organisations (PRO’s)

Support and networking for your (potential) spin-offs.

Expert sessions, pitchtraining and webinars provide feedback for you and the entrepreneurs you work with.

Investors & industry partners

An unique sneakpeak into the upcoming spin-off initiatives from all Benelux knowledge institutes in the human health.

Spin off initiatives are selected and supported in the preperation for their pitch or Quickfire presentations at our informal events.

HIHR-14 May 2024


  • 9 online Quickfire sessions from May 6 to May 8 (9am, 12am and 5pm)
  • a KTO Meet up on May 15, 10.00 – 11.30
  • and our live pitch edition with 11 opportunities in Antwerp on the afternoon of May 15 (the eve of Knowledge for Growth). 

We happily welcome you in a Room with a Zoo to connect with the newest academic Health Spin-offs from the Benelux.

HIHR helped us enormously in improving our pitch.

Pieter Roelfsema, Phosphoenix

At HIHR 2019 we had the opportunity as an academic team to pitch our spin-off project to a group of investors. After teaming up with an experienced entrepreneur and thorough due diligence, we successfully secured funding from some of those investors.

Kevin Braeckmans, Trince

Great opportunity to get honest feedback from a great panel of experts and investors, even for projects in a rather early stage (QF Sessions).

Sven Arnouts, Ghent University

As an early stage investor, HIHR is a unique opportunity to meet entrepreneurs in life sciences that are motivated to bring their work to patients. In addition, the meeting clearly has an objective to have benefits for all involved. I learned a lot from both presenters as well as questions from the audience.

Kjell Mortier, Novalis Biotech

Golden Partner

Silver Partners

Other participating funds

Many leading funds and venture developers are participating in our events. Found out here the list of all investors and industry partners that have joined our pitch sessions.